ClinConnect ClinConnect Logo
Search / Trial NCT03215134

Self-Criticism Feasibility Study

Launched by KING'S COLLEGE LONDON · Jul 10, 2017

Trial Information

Current as of June 05, 2025

Completed

Keywords

Improving Access To Psychological Therapies (Iapt) Primary Mental Health Service Compassion Focused Therapy (Cft)

ClinConnect Summary

The intervention is based upon recent unpublished doctoral research that developed this novel treatment within students with high levels of self-criticism. This pilot study aims to adapt the intervention for an Improving Access to Psychological Therapies (IAPT) service, a primary mental-health service in the UK.

Self-criticism is a transdiagnostic process across common mental-health disorders and is therefore, a potential target for psychological intervention. Clients at IAPT are likely to present with high levels of self-criticism. This pilot study may help develop an alternative evidence...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Written informed consent
  • 2. Registered with and opt into the Southwark IAPT service, Talking Therapies Southwark
  • 3. Score at least 10 on the WSAS questionnaire regarding the impact of self-criticism on their daily life
  • 4. Requesting help for their self-criticism.
  • Exclusion Criteria:
  • 1. Not being sufficiently proficient in English to fully participate in the sessions with English-speaking therapists or process the written study materials for any reason.
  • 2. Being unable to attend six sessions of assessment/treatment.
  • 3. Presenting with high levels of risk requiring monitoring and assistance beyond the weekly intervention focusing on self-criticism.
  • 4. Current serious mental health problem such as bipolar disorder, anorexia nervosa or a moderate / severe substance use disorder.
  • 5. Cognitive impairment or psychomotor retardation of a degree that would prevent completion of the study treatment protocol with the individual. This would be based on a clinical judgement by potential referrers or by the clinician undertaking the screening assessment.
  • 6. Currently experiencing a degree of life stress (e.g. recent bereavement) that is judged by the assessor to be likely to seriously adversely affect their ability to benefit from the intervention
  • 7. New pharmacological interventions for psychological distress - i.e. a change of medication or dosage in the last 4 weeks.
  • 8. Current participation in another clinical (talking therapy or drug) trial or another psychological intervention.

About King's College London

King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Mehul Elliott-Joshi

Principal Investigator

Institute of Psychiatry, Psychology and Neuroscience (IoPPN), Kings College London; South London and Maudsley (SLaM) NHS Foundation Trust

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials